Çene kemiklerinin yeni tehlikesi: bisfosfonatlar

Volume: 11 Number: 2 November 4, 2011
EN TR

Çene kemiklerinin yeni tehlikesi: bisfosfonatlar

Abstract

Bisphosphonate compounds have been used for the improvement of the lives of cancer patients by reducing complications such as hypercalcemia. They are preferred to treat bone metastases of solid tumors such as breast, prostate and lung cancer, and also utilized in the management of lytic lesions of multiple myeloma. Intravenous administration of high doses of bisphosphonates for the management of benign conditions occasionally lead to the development of osteonecrosis of the jaws. In many cases lesions appear spontaneously, or following an infection or a dental extraction. At present, there is no definite treatment for this particular druginduced necrosis of bone except conservative debridement of bone lesions, oral antibiotics and local irrigations. It is important to recognize the clinical and radiographic features of the bisphosohonate osteonecrosis of the jaws in order to provide early diagnosis and to improve the care of these patients.

 

ÖZET

Bisfosfonat bileşikleri malignansiye bağlı olarak gelişen hiperkalseminin düzenlenmesinde ve ayrıca, meme, prostat ve akciğer kanserlerine bağlı tümörlerin ve multipl myelomaya bağlı metastatik lezyonların tedavisinde kanser hastalarının hayat kalitelerini iyileştirmek amacıyla kullanılmaktadır. Bisfosfonatların yüksek dozlarda intravenöz olarak uygulanmaları nedeniyle ilaca bağlı bir yan etki olarak çenelerde osteonekroz gelişebilmektedir. Lezyonlar kendiliğinden oluşabildiği gibi, bir enfeksiyon ve diş çekimi genellikle olayı hızlandırmaktadır. İlaca bağlı olarak gelişen bu özgün kemik nekrozu için henüz kesin bir tedavi bulunmamaktadır. Konservatif yaklaşım uygulanan vakalarda, kemiğin açığa çıkmış olduğu hastaların büyük bölümünde oral antibiyotikler, antienflamatuvarlar ve açık yara bölgesinin lokal irrigasyonu önerilmektedir. Bisfosfonat osteonekrozuna ait klinik ve radyografik özelliklerin iyi bilinmesi ve bu tür hastalarda klinik ve radyolojik belirtilerin değerlendirilmesi, erken tanı ve tedavi açısından da önem taşımaktadır.

Anahtar Kelimeler: Bisfosfonatlar, osteonekroz, metastaz, hiperkalsemi, çene

Keywords

References

  1. Alıcı S, Çekici S. Malign hastalıklarda bisfosfonatların rolü. Van Tıp Dergisi 2002; 9: 66-72.
  2. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006; 17: 897-907.
  3. Wikipedia: http://en.wikipedia.org/wiki/Bisphosphonate
  4. Wang EP, Kaban LB, Strewler GJ, Raje N, Toulis MJ. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 2007; 65: 1328-1331.
  5. Duman AE, Güven GS, Gürlek A. Erkek osteoporozu. Hacettepe Tıp Dergisi 2005; 36: 175-183.
  6. Benhamou CL. Effects of osteoporosis medications on bone quality. Joint Bone Spine 2007; 74: 39-47.
  7. Berardi D, Carlesi T, Rossi F, Calderini M, Volpi R, Perfetti G. Potential applications of bisphosphonates in dental surgical implants. Int J Immunopathol Pharmacol 2007; 20: 455-465.
  8. Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 2005; 32: 1123-1128.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Pelin Guneri

Huseyin Koca

Publication Date

November 4, 2011

Submission Date

November 4, 2011

Acceptance Date

-

Published in Issue

Year 2008 Volume: 11 Number: 2

EndNote
Ergun S, Guneri P, Koca H (November 1, 2011) Çene kemiklerinin yeni tehlikesi: bisfosfonatlar. Cumhuriyet Dental Journal 11 2 134–139.

Cumhuriyet Dental Journal (Cumhuriyet Dent J, CDJ) is the official publication of Cumhuriyet University Faculty of Dentistry. CDJ is an international journal dedicated to the latest advancement of dentistry. The aim of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of dentistry. First issue of the Journal of Cumhuriyet University Faculty of Dentistry was published in 1998. In 2010, journal's name was changed as Cumhuriyet Dental Journal. Journal’s publication language is English.


CDJ accepts articles in English. Submitting a paper to CDJ is free of charges. In addition, CDJ has not have article processing charges.

Frequency: Four times a year (March, June, September, and December)

IMPORTANT NOTICE

All users of Cumhuriyet Dental Journal should visit to their user's home page through the "https://dergipark.org.tr/tr/user" " or "https://dergipark.org.tr/en/user" links to update their incomplete information shown in blue or yellow warnings and update their e-mail addresses and information to the DergiPark system. Otherwise, the e-mails from the journal will not be seen or fall into the SPAM folder. Please fill in all missing part in the relevant field.

Please visit journal's AUTHOR GUIDELINE to see revised policy and submission rules to be held since 2020.